Drugs,                           
           Digitalisation, 
                                    Transformation



From Devil's Stuff to Miracle Cure?

  • PD Dr. Marc Vogel, Universitäre Psychiatrische Kliniken Basel, Division of Substance Use Disorders
    • What are we talking about? Substance use, misuse and abuse - what does stigma have to do with it?


  • Prof Dr. Alois Stutzer, University of Basel, Faculty of Business & Economics 
    • Cannabis: From Reefer Madness to Medicine?


  • Dr. Evangelos Avramakis, Head of Digital Ecosystems R&D, Swiss Re Institute, Zürich
    • Connect and Engage Digitally - It is Worth it!: Why data exchange and networks matter to the healthcare community


  • Guillaume Krepper, Sustainable Investment Analyst, Bank J Safra-Sarasin
    • What the Health! – The Investor Perspective


  • Alastair Scarlett, Consultant Life Sciences, d-wise, UK
    • Everything Looks Better through Rose-Tinted Glasses – Automating Adverse Events Narratives


  • PD Dr. Marc Vogel, Universitäre Psychiatrische Kliniken Basel, Division of Substance Use Disorders
    • Good, bad or ugly? Opioids between medication and drugs of abuse


  • Damian Schraube, IT Consultant, WEGA Informatik
    • Today the World, Tomorrow the Universe! Approaches and Challenges in Big Data Environments


  • Prof Dr. Matthias E. Liechti, University Hospital Basel, Clinical Pharmakology
    • Ecstasy & LSD – Substances of Abuse or Medication?








See our Speakers and Presentations